Tag Archives: MOSY

Top 5 Stocks To Watch For 2019

Brokerages forecast that Imax Corp (NYSE:IMAX) will report $79.17 million in sales for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Imax’s earnings, with the lowest sales estimate coming in at $72.16 million and the highest estimate coming in at $82.90 million. Imax posted sales of $98.80 million in the same quarter last year, which indicates a negative year over year growth rate of 19.9%. The company is expected to announce its next quarterly earnings results on Thursday, October 25th.

On average, analysts expect that Imax will report full-year sales of $378.78 million for the current fiscal year, with estimates ranging from $364.05 million to $392.60 million. For the next fiscal year, analysts anticipate that the firm will report sales of $411.35 million per share, with estimates ranging from $404.57 million to $423.30 million. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that cover Imax.

Top 5 Stocks To Watch For 2019: Castlight Health, inc.(CSLT)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Castlight Health (CSLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Inovalon (NASDAQ:INOV) and Castlight Health (NYSE:CSLT) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

  • [By Logan Wallace]

    Castlight Health Inc (NYSE:CSLT) has been given an average rating of “Buy” by the eight ratings firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $5.56.

  • [By Ethan Ryder]

    Castlight Health Inc (NYSE:CSLT) shot up 2.6% on Monday . The stock traded as high as $3.10 and last traded at $2.97. 6,914 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 535,927 shares. The stock had previously closed at $3.05.

  • [By Stephan Byrd]

    Fmr LLC grew its holdings in shares of Castlight Health Inc (NYSE:CSLT) by 2.1% during the second quarter, Holdings Channel reports. The institutional investor owned 12,620,881 shares of the software maker’s stock after buying an additional 254,616 shares during the period. Fmr LLC owned 0.09% of Castlight Health worth $53,639,000 at the end of the most recent quarter.

Top 5 Stocks To Watch For 2019: H&R Block, Inc.(HRB)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TheStreet upgraded shares of H & R Block (NYSE:HRB) from a c+ rating to a b rating in a report released on Tuesday.

    Other equities research analysts have also issued research reports about the company. Barrington Research lowered their price objective on H & R Block from $32.00 to $27.00 and set an outperform rating for the company in a research note on Thursday. ValuEngine downgraded H & R Block from a sell rating to a strong sell rating in a report on Wednesday. Morgan Stanley reaffirmed an equal weight rating and set a $28.00 target price (up previously from $27.00) on shares of H & R Block in a report on Wednesday, March 7th. BMO Capital Markets reduced their target price on H & R Block from $29.00 to $25.00 and set a market perform rating on the stock in a report on Wednesday. Finally, Zacks Investment Research downgraded H & R Block from a strong-buy rating to a hold rating in a report on Tuesday, March 27th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. H & R Block presently has a consensus rating of Hold and a consensus price target of $26.21.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on H & R Block (HRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Paul Ausick]

    H&R Block Inc. (NYSE: HRB) traded down about 1.2% Tuesday and posted a new 52-week low of $23.28 after closing Monday at $23.55. The stock’s 52-week high is $31.80. Volume totaled about 3.1 million, about a third higher than the daily average of around  3.2 million. The company had no specific news. Shares have turned around and are headed for a gain of about 1.4% at the closing bell.

  • [By Matthew Frankel]

    For tax preparation specialist H&R Block (NYSE:HRB), the first quarter of the calendar year (the company’s fiscal fourth quarter) is by far the busiest. After all, that’s when most of tax season happens.

  • [By Jim Crumly]

    As for individual stocks, newly public Pivotal Software (NYSE:PVTL) wowed investors with its quarterly results, and H&R Block (NYSE:HRB) delivered a disappointing outlook.

Top 5 Stocks To Watch For 2019: China Cord Blood Corporation(CO)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Global Cord Blood (NYSE:CO) Q4 2018 Earnings Conference CallJun. 27, 2018 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Alta Mesa Resources (NASDAQ: AMR) and Global Cord Blood (NYSE:CO) are both oils/energy companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

  • [By Max Byerly]

    Global Cord Blood (NYSE: CO) and Alta Mesa Resources (NASDAQ:AMR) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

  • [By Shane Hupp]

    Shares of Global Cord Blood Corp (NYSE:CO) dropped 5.8% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $9.05 and last traded at $9.34. Approximately 677,976 shares traded hands during mid-day trading, an increase of 222% from the average daily volume of 210,845 shares. The stock had previously closed at $9.92.

Top 5 Stocks To Watch For 2019: MoSys, Inc.(MOSY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 27 percent to $1.9265 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MoSys (MOSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 5 Stocks To Watch For 2019: Potlatch Corporation(PCH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Sei Investments Co. grew its position in Potlatchdeltic Corp (NASDAQ:PCH) by 39.9% during the 1st quarter, HoldingsChannel reports. The firm owned 68,663 shares of the real estate investment trust’s stock after acquiring an additional 19,589 shares during the quarter. Sei Investments Co.’s holdings in Potlatchdeltic were worth $3,574,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Potlatchdeltic (PCH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Potlatchdeltic (PCH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Potlatchdeltic (NASDAQ:PCH) declared that its Board of Directors has initiated a stock repurchase plan, which allows the company to repurchase $100.00 million in outstanding shares on Thursday, August 30th. This repurchase authorization allows the real estate investment trust to buy up to 3.3% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s management believes its shares are undervalued.

  • [By Stephan Byrd]

    Shares of Potlatchdeltic Corp (NASDAQ:PCH) have received an average recommendation of “Hold” from the nine ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $49.60.

  • [By Max Byerly]

    Shares of Potlatchdeltic Corp (NASDAQ:PCH) have received an average rating of “Hold” from the ten research firms that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $50.83.

Hot Performing Stocks To Own For 2019

L Brands (LB) soared to the top of the S&P 500 today after the parent company of Victoria’s Secret reported a 10% drop in same-store sales.

Agence France-Presse/Getty Images

L Brands surged 11% to $47.85 today, while the S&P 500 rose 0.2% to 2,357.49. And while L Brands was the best performer, retailers made up half of the 10 best performing stocks in the benchmark today: Nordstrom (JWN) advanced 2.9% to $44.71, Gap (GPS) jumped 5.1% to $24.06, Kohl’s (KSS) climbed 5.6% to $39.60, and Bed Bath & Beyond (BBBY), which reported earnings last night, gained 3.4% to $39.08.

RBC analysts Brian Tunick and Kate Fitzsimons attributed L Brand’s big move to a short squeeze. They explain:

Bottom line, with the stock recently hitting a 52 week low yesterday, the 10% squeeze we’re seeing in the shares is likely reflective of the “better-than-feared” trade rather than long-only buyers stepping in. The reality is that LB’s fundamentals are still challenged (down 10% comps are nothing to throw a party for), with the overhang on LB shares related to how much of the damage is self-inflicted (7% category exit headwind called out this month) vs. a tough mall traffic environment. Net/net, we remain neutral on LB shares given the lack of top line visibility as LB executes these category exits, with April and 2Q17’s merch margin commentary ones to watch for signals that we’ve rounded the bottom.

Hot Performing Stocks To Own For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Max Byerly]

    Intesa Sanpaolo (BIT:ISP) received a €3.00 ($3.53) price target from stock analysts at HSBC in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. HSBC’s target price points to a potential downside of 2.60% from the stock’s current price.

  • [By Stephan Byrd]

    Goldman Sachs Group set a €2.90 ($3.37) price target on Intesa Sanpaolo (BIT:ISP) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

Hot Performing Stocks To Own For 2019: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights, Chuck Saletta, and Brian Feroldi]

    That’s the question we presented to three Motley Fool contributors. They identified Ligand Pharmaceuticals (NASDAQ:LGND), Portola Pharmaceuticals (NASDAQ:PTLA), and Supernus Pharmaceuticals (NASDAQ:SUPN) as top biotech stocks to buy in September. Here’s why these biotechs stood out:

  • [By Keith Speights]

    Which companies that are relatively small right now could become the big biotechs of the future? Here’s why I think that Editas Medicine (NASDAQ:EDIT), Ligand Pharmaceuticals (NASDAQ:LGND), and Exelixis (NASDAQ:EXEL) could be monster biotech stocks in the making.

  • [By Shane Hupp]

    Ligand Pharmaceuticals Inc. (NASDAQ:LGND) Director Todd C. Davis sold 9,000 shares of Ligand Pharmaceuticals stock in a transaction on Friday, August 17th. The shares were sold at an average price of $239.78, for a total transaction of $2,158,020.00. Following the transaction, the director now owns 44,806 shares in the company, valued at approximately $10,743,582.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Performing Stocks To Own For 2019: MoSys, Inc.(MOSY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MoSys (MOSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 27 percent to $1.9265 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 10 Medical Stocks To Own For 2018

By Emmanuel Enemchukwu with Hien X. T. Nguyen, Chenxi Liu, and Elizabeth Ren

Typical of REITs, the most compelling investment thesis for a Healthcare REIT like Medical Property Trust (MPW) has usually been the generous dividend payout. The generosity of its dividends not taken for granted, our valuation of MPW makes a case for underpricing. We are convinced that $17.20 per share – at the very least – is a more accurate reflection of the future prospects built into MPW’s fundamentals. At a current price of $12.66, this represents a whopping 36% upside.

Reality has played out rather differently for MPW. The stock price is back to where it was March when the bankruptcy proceedings of Adeptus – one of its biggest tenants – sent investors scampering. The entire Adeptus issue turned out to be overblown – further discussions later – but it also emblematized the challenges of the wider Medical REITs space. Nevertheless, we are convinced that an eventual appreciation is certain.

Top 10 Medical Stocks To Own For 2018: Pound/Rand(PX)

Advisors’ Opinion:

  • [By Shane Hupp]

    TT International purchased a new stake in Praxair (NYSE:PX) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 66,633 shares of the basic materials company’s stock, valued at approximately $9,615,000. Praxair makes up about 0.4% of TT International’s portfolio, making the stock its 26th biggest position.

  • [By Lisa Levin] Companies Reporting Before The Bell
    General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion.
    Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion.
    United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion.
    Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion.
    ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion.
    PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion.
    American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion.
    Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion.
    Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion.
    Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion.
    D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion.
    The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion.
    Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion.
    Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion.
    Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion.
    Oshkosh Corporation (NYSE: OSK) is projected to report quarter
  • [By Logan Wallace]

    D.A. Davidson & CO. boosted its position in shares of Praxair (NYSE:PX) by 78.0% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 5,321 shares of the basic materials company’s stock after acquiring an additional 2,332 shares during the quarter. D.A. Davidson & CO.’s holdings in Praxair were worth $768,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Own For 2018: Oasis Petroleum Inc.(OAS)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Amazon.com Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By Max Byerly]

    Oasis Petroleum (NYSE:OAS) has been given a $10.00 price target by equities researchers at Stifel Nicolaus in a report issued on Tuesday. The brokerage presently has a “hold” rating on the energy producer’s stock. Stifel Nicolaus’ target price points to a potential downside of 11.82% from the stock’s current price.

  • [By Benzinga News Desk]

    The curtain could come down any day on MoviePass’ bumpy run as an independent company: Link

    ECONOMIC DATA
    Chicago Fed national activity index +0.10 vs +0.27 expected
    The Composite Purchasing Managers' Index for April will be released at 9:45 a.m. ET.
    Existing home sales report for March is schedule for release at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    ANALYST RATINGS
    Deutsche Bank upgraded Michael Kors (NYSE: KORS) from Hold to Buy
    RBC downgraded Paylocity (NASDAQ: PCTY) from Outperform to Sector Perform
    Suntrust downgraded Oasis Petroleum (NYSE: OAS) from Hold to Sell

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Akorn, Inc. (NASDAQ: AKRX) fell 32.7 percent to $13.25 in pre-market trading after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 15.7 percent to $12.30 in pre-market trading. Subsea 7 confirmed a $7.00 per share proposal to acquire Mcdermott, pending termination of merger agreement with CB&I.
    Myomo, Inc. (NYSE: MYO) fell 9 percent to $3.65 in pre-market trading after rising 11.39 percent on Friday.
    Hasbro, Inc. (NASDAQ: HAS) fell 8 percent to $88.36 in pre-market trading after the company reported weaker-than-expected results for its first quarter on Monday.
    SunPower Corporation (NASDAQ: SPWR) fell 7.1 percent to $9.00 in pre-market trading.
    Endeavour Silver Corp. (NYSE: EXK) shares fell 5.9 percent to $2.88 in pre-market trading after declining 3.16 percent on Friday.
    Mattel, Inc. (NASDAQ: MAT) shares fell 5.5 percent to $12.25 in pre-market trading.
    Valeritas Holdings, Inc. (NASDAQ: VLRX) shares fell 5.1 percent to $2.96 in pre-market trading after rising 76.27 percent on Friday.
    GlobalSCAPE, Inc. (NYSE: GSB) fell 5.1 percent to $3.57 in pre-market trading.
    Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) shares fell 4.1 percent to $49.93 in pre-market trading.
    Oasis Petroleum Inc. (NYSE: OAS) fell 4.1 percent to $9.75 in pre-market trading. SunTrust Robinson Humphrey downgraded Oasis Petroleum from Hold to Sell

Top 10 Medical Stocks To Own For 2018: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Catalyst Biosciences (CBIO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    B. Riley set a $44.00 price target on Catalyst Biosciences (NASDAQ:CBIO) in a report published on Monday. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. B. Riley also issued estimates for Catalyst Biosciences’ Q1 2019 earnings at ($0.85) EPS, Q2 2019 earnings at ($0.91) EPS, Q3 2019 earnings at ($0.98) EPS and Q4 2019 earnings at ($1.13) EPS.

Top 10 Medical Stocks To Own For 2018: MoSys, Inc.(MOSY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 27 percent to $1.9265 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 21 percent to $1.84 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

Top 10 Medical Stocks To Own For 2018: Ford Motor Company(F)

Advisors’ Opinion:

  • [By Paul Ausick]

    Ford Motor Co. (NYSE: F) traded down about 3.4% Monday and posted a new 52-week low of $10.35 after closing Friday at $10.71. The stock’s 52-week high is $13.48. Volume was around 67 million, nearly 65% above the daily average of about 40 million shares. The company had no specific news.

  • [By ]

    That’s decent news for Mother Earth, but potentially challenging news for automakers such as Ford (F) and General Motors (GM) given the high R&D expenses needs to support electric car roll-outs.

  • [By ]

    Here’s everything you must know before Thursday’s opening bell:

    Facebook (FB) posted first-quarter earnings and revenue that beat analysts’ expectations. Ford (F) plans to shed most of its North American car lineup as customer preference has shifted to pickups and crossovers.  Deutsche Bank (DB) said it was planning “significant” job cuts for its global investment banking division. Investors will analyze earnings from Amazon (AMZN) and Microsoft (MSFT) .    U.S. stock futures pointed toward a modestly higher open.

    Subscribe to our Youtube Channel for extended interviews, Cramer Replays, feature content, and more!

  • [By ]

    Ford Motor Co. (F) will resume production of its F-150 and Super Duty pickups after a fire at a parts supplier forced the automaker to suspend production, which will hit second-quarter earnings, the company announced Wednesday, May 16.  

  • [By Daniel Miller]

    Some investors are still surprised when they find out that the financial divisions of Ford Motor Co. (NYSE:F) and General Motors (NYSE:GM) are among the most profitable parts of the automakers’ operations.

  • [By Douglas A. McIntyre]

    General Motors Co.’s (NYSE: GM) Cadillac was rumored to begin to prune its dealer network in 2015, but the decision was shelved. Whether manufacturers GM and Ford Motor Co. (NYSE: F) might completely spin out Lincoln and Cadillac dealers from those thatsell nonluxury brands may depend in part on the Hyundai experiment. BMW, Mercedes and Audi have the benefit that their sales and service operations are not generally married to those of less expensive cars.

Top 10 Medical Stocks To Own For 2018: Franco-Nevada Corporation(FNV)

Advisors’ Opinion:

  • [By Shane Hupp]

    ARP Americas LP cut its position in Franco-Nevada (NYSE:FNV) (TSE:FNV) by 35.9% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 7,441 shares of the basic materials company’s stock after selling 4,167 shares during the period. ARP Americas LP’s holdings in Franco-Nevada were worth $507,000 as of its most recent SEC filing.

  • [By David Zeiler]

    “If you look back to the 70s, 80s and 90s, in every of those decades the industry found at least one 50+ million ounce gold deposit, at least ten 30+ million ounce deposits and countless five to 10 million ounce deposits. But if you look at the last 15 years, we found no 50 million ounce deposit, no 30 million ounce deposit and only very few 15 million ounce deposits,” Pierre Lassonde, chair of gold royalty and income stream company Franco-Nevada Corp. (NYSE: FNV), told German financial newspaper Finanz und Wirtschaft last October.

  • [By Dan Caplinger]

    Franco-Nevada (NYSE:FNV) went public in the U.S. market more than a decade ago, and over that time, the company has established itself as a major player in an important niche in the natural resources industry. Franco-Nevada neither mines gold nor drills for oil, but by helping to finance projects that mining companies and oil drillers want to pursue, it ensures it can get a cut of the profits. That’s been a winning business model lately, and throughout its history as a publicly traded company, Franco-Nevada has stood out for one thing that it’s done consistently well: paying and raising its dividend regularly over time.

Top 10 Medical Stocks To Own For 2018: Semtech Corporation(SMTC)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    The wealthy are hoarding $10 billion of bitcoin in bunkers: Link $

    ECONOMIC DATA
    US May MBA mortgage applications -0.4% vs, -2.5% prior
    USA Core PPI (MoM) for Apr 0.20% vs 0.20% Est; Prior 0.30%. USA PPI (MoM) for Apr 0.10% vs 0.20% Est; Prior 0.30%
    Data on wholesale trade inventories for March will be released at 10:00 a.m. ET.
    The Energy Information Administration’s weekly report on petroleum inventories in the U.S. is schedule for release at 10:30 a.m. ET.
    The Treasury is set to auction 10-year notes at 1:00 p.m. ET.
    Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 1:15 p.m. ET.
    ANALYST RATINGS
    Cantor upgraded Arrowhead Pharmaceuticals (NASDAQ: ARWR) from Neutral to Overweight
    RBC upgraded Semtech (NASDAQ: SMTC) from Sector Perform to Outperform
    Morgan Stanley downgraded Adient (NYSE: ADNT) from Overweight to Equal-Weight
    Jefferies downgraded Beacon Roofing (NASDAQ: BECN) from Buy to Hold

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Top 10 Medical Stocks To Own For 2018: BYD Company Limited (BYDDY)

Advisors’ Opinion:

  • [By ]

    BYD Co. (OTCPK:BYDDY), (OTCPK:OTCPK:BYDDF) HK:1211

    BYD is currently ranked the number 2 globally with 9% global market share, and is ranked number 1 in China with 24% market share.

  • [By ]

    Chinese electric-car startup NIO (formerly known as NextEV), which has attracted three of China’s famous BATX tech giants, namely, Baidu (BIDU), Tencent (OTCPK:TCEHY) (OTCPK:TCTZF), and Xiaomi (XI) as investors, is also based in Shanghai. Singapore’s state investment vehicle Temasek Holdings and computing titan Lenovo Group (OTCPK:LNVGY) (OTCPK:LNVGF) are also early backers of NIO. Qoros Automotive, a 50-50 joint venture between Chinese state-owned Chery Automobile and Singaporean investment company Kenon Holdings, is headquartered in Shanghai, while its assembly plant in Changshu is near Shanghai. Looking elsewhere in China, BYD Co. Ltd. (OTCPK:BYDDF) (OTCPK:BYDDY), a Chinese EV-maker backed by Warren Buffett’s Berkshire Hathaway (BRK.A) (BRK.B), has manufacturing sites in Shenzhen, Huizhou, Shanxi, and Shanghai.

Top 10 Medical Stocks To Own For 2018: Park-Ohio Holdings Corp.(PKOH)

Advisors’ Opinion:

  • [By Max Byerly]

    Park-Ohio (NASDAQ:PKOH) is set to post its quarterly earnings results before the market opens on Wednesday, May 9th. Analysts expect Park-Ohio to post earnings of $0.80 per share for the quarter.

  • [By Stephan Byrd]

    Park-Ohio (NASDAQ: PKOH) and Materion (NYSE:MTRN) are both small-cap industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, dividends, risk, analyst recommendations, earnings and valuation.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Park-Ohio (PKOH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2018: Royal Dutch Shell PLC(RDS.A)

Advisors’ Opinion:

  • [By Alexander Bird]

    Much of Wall Street will tell you to stick with the oil industry giants – companies like Exxon Mobil Corp. (NYSE: XOM) or Royal Dutch Shell Plc. (NYSE: RDS.A).

Top 5 Low Price Stocks To Buy Right Now

After struggling through deregulation, high oil prices, and a lengthy recession, airline stocks have rebounded in synchronization with the US stock market, with better global economies, and generally as a leading US economic indicator. A simple comparison of the six largest US airlines gives an encouraging picture of the recovery.

Of course, investors should be aware that airlines legendarily compete head-on in most markets: United, for example, has just said that despite stronger-than-expected fourth quarter revenues, it will add capacity and match others’ low prices.

Market Capitalization, Stock Price, and Current vs. 52-week High

As of the January 23, 2018 close, the market capitalizations of these companies are Delta (DAL) at $42.5 billion, Southwest (LUV) at $38.7 billion, American (AAL) at $27.9 billion, United Continental (UAL) at $23 billion, Alaska Air Group (ALK) at $8.5 billion, and JetBlue (JBLU) at $7.2 billion. Note that Alaska Air Group recently acquired Virgin America.

Top 5 Low Price Stocks To Buy Right Now: Euronet Worldwide Inc.(EEFT)

Advisors’ Opinion:

  • [By Asit Sharma]

    Electronic payments and remittances giantEuronet Worldwide (NASDAQ:EEFT)displayed crisp revenue growth in its earnings report issued April 25, which covered the first three months of the current year. Below, we’ll outline summary numbers, delve into pertinent details underlying the results, and review management’s perspective on the quarter:

Top 5 Low Price Stocks To Buy Right Now: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca

Top 5 Low Price Stocks To Buy Right Now: MoSys, Inc.(MOSY)

Advisors’ Opinion:

  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 27 percent to $1.9265 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 21 percent to $1.84 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 5 Low Price Stocks To Buy Right Now: Luby's, Inc.(LUB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

  • [By Max Byerly]

    Headlines about Luby’s (NYSE:LUB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Luby’s earned a news impact score of 0.10 on Accern’s scale. Accern also gave news coverage about the restaurant operator an impact score of 47.2262144037183 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 5 Low Price Stocks To Buy Right Now: region(XIV)

Advisors’ Opinion:

  • [By Money Morning News Team]

    This led some traders to purchase leveraged ETFs that move inverse to the VIX, like theVelocityShares Daily Inv VIX Short Term(Nasdaq: XIV).

    The VIX is a derivative of the broad S&P 500, and the XIV is a derivative of that derivative.